Article Sidebar

PDF (Tiếng Việt)
Published: 2025-09-25
Abstract Views: 20
Views PDF (Tiếng Việt): 19
DOI: https://doi.org/10.52163/yhc.v66iCD13.3217
Issue
Vol. 66 No. CĐ13- HNKH Gây mê Hồi sức
Section
Articles
How to Cite
Tuấn, Đinh T., Đồng, T. T., Hưng, T. Q., Hoài, V. T., & Trường, Đỗ T. (2025). 57. ASSESSMENT OF OVERALL SURVIVAL FOLLOWING TRANSURETHRAL RESECTION FOR ADVANCED-STAGE PROSTATE CANCER COMBINED WITH BILATERAL ORCHIECTOMY: A RETROSPECTIVE STUDY AT VIET DUC HOSPITAL FROM JANUARY 2018 TO DECEMBER 2022. Vietnam Journal of Community Medicine, 66(CĐ13- HNKH Gây mê Hồi sức). https://doi.org/10.52163/yhc.v66iCD13.3217

57. ASSESSMENT OF OVERALL SURVIVAL FOLLOWING TRANSURETHRAL RESECTION FOR ADVANCED-STAGE PROSTATE CANCER COMBINED WITH BILATERAL ORCHIECTOMY: A RETROSPECTIVE STUDY AT VIET DUC HOSPITAL FROM JANUARY 2018 TO DECEMBER 2022

Dinh Thanh Tuan1, To Thanh Dong1, Tran Quang Hung2, Vu Thu Hoai1, Do Thanh Truong3
1 Department of Mathematics - Informatics, Hanoi Medical University
2 Department of Surgery, National Hospital of Traditional Medicine
3 Department of Surgery and Urology, Viet Duc University Hospital

Main Article Content

Abstract

Objective: To evaluate the overall survival time following transurethral resection for advanced stage prostate cancer combined with bilateral orchiectomy at Viet Duc University Hospital from January 2018 to December 2022.


Research methods: The retrospective followed up longitudinally on 217 patients diagnosed with advanced prostate cancer who underwent transurethral resection of the tumor with bilateral orchiectomy.


Results: There were 99 patients who died, accounting for 45.6%. The survival rate decreased gradually over the follow-up time in the groups from 24 to 72 months after surgery, corresponding to 67.1% to 36.8%. The main cause of death was cancer metastasis to other organs. Factors affecting survival rate and overall survival time were Gleason score, age group and stage of Prostate cancer (p < 0.05). The average survival time of all patients studied was 45.4 months and 50% of patients survived 49 months. The average survival time of deceased patients was 22.41 ± 14.3 (months) with the shortest being 1 month and the longest being 62 months.


Conclusion: There was a correlation between survival rate and overall survival time with Gleason score, advanced age and prostate cancer stage. The average survival time of all study patients was 45.4 months, and that of deceased patients was 22.41 ± 14.3 (months).

Article Details

Keywords

Prostate cancer, post-operative results, median survival time.

References

[1] WHO. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021 Feb 4.
[2] Turkbey B, Rosenkrantz A.B, Haider M.A et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol, 2019, 76 (3): 340-351.
[3] Lê Thị Khánh Tâm. Đánh giá kết quả điều trị nội tiết ung thư tuyến tiền liệt giai đoạn IV. Luận án tiến sĩ y học, Trường Đại học Y Hà Nội, 2020.
[4] Bechis S.K, Carroll P.R, Cooperberg M.R. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol, 2011, 29 (2), 235-41.
[5] Tsao C.K et al. Patients with biopsy Gleason 9 and 10 prostate cancer have significantly worse outcomes compared to patients with Gleason 8 disease. The Journal of Urology, 2015, 194 (1), 91-97.
[6] Ma C.G et al. The survival analysis of metastatic prostate cancer. Chinese Journal of Surgery, 2010 Aug 1, 48 (15): 1166-9. PMID: 21055012 Chinese.